We sit down with you and build your perfect lead list. Book a call with founders.

Abzu Analysis: $11M Raised

What is Abzu?

Abzu specializes in AI-powered drug design, focusing on RNA therapeutics. Their unique approach combines explainable AI with data-driven methodologies to enhance drug discovery. This results in higher success rates and faster development timelines for pharmaceutical research and development.

HQ Country
Copenhagen, Denmark
Employees
11-50
Founded
2018
Industry
AI/ML, Biotech, HealthTech

Product Features & Capabilities

  • AI-guided drug design process for RNA therapeutics
  • Predictive models for drug properties like activity and cross-reactivity
  • Ready-to-use compound designs with detailed selection reports
  • One-stop solution for design and in-vitro validation
  • Integration of existing data into predictive models.

How much Abzu raised

Grant (prize money) - $2.43M

Oct 15, 2022
Lead Investor: EIC Fund

Seed - $6.87M

Feb 26, 2021
Lead Investor: Seed Capital, Inventure, and 2 more

Seed - $63.6K

Sep 04, 2020
Lead Investor: None listed

Seed - $1.92M

Jul 05, 2019
Lead Investor: Nordic Ventures, Inventure, and 1 more

Seed - $178K

Jan 25, 2018
Lead Investor: PSV Deeptech

Financial Overview

$11MTotal Raised
Grant (prize money)$2.43M
Oct 15, 2022
Investors: EIC Fund
Seed$6.87M
Feb 26, 2021
Investors: Seed Capital, Inventure, and 2 more
Seed$63.6K
Sep 04, 2020
Investors: None listed
Seed$1.92M
Jul 05, 2019
Investors: Nordic Ventures, Inventure, and 1 more
Seed$178K
Jan 25, 2018
Investors: PSV Deeptech
Want to research more data points on Abzu?
Start with Extruct